This is a phase I, randomised, double-blind, placebo-controlled, 3-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of WD-910 in in Healthy Participants Detailed

Inclusion Criteria:

• Aged 18 to 55 years (inclusive) at the time of informed consent.
• Body mass index (BMI) between 18 to 32 kg/m2 and male participant with body weight of ≥ 50.0 kg, female participant with body weight ≥ 45.0 kg

Exclusion Criteria:

• Any major surgery within 12 weeks prior to Day 1, or any planned surgery during the study.
• Poor pill swallowing ability